1. Processes and perceptions of chemotherapy supply chain in Ethiopia: A mixed-method study.
- Author
-
Stocker, Kurtis J, Tiemann, Andrew, Brunk, Kelly M, Agegnehu, Bemnat, Buhlinger, Kaitlyn, Amerine, Lindsey, Roberts, Megan C, McLaughlin, Jacqueline E, Clark, Stephen M, Rose, Robert, Mekonnen, Befikadu, Bhakta, Nickhill, Fentie, Atalay Mulu, Alexander, Thomas B, Ozawa, Sachiko, Chargualaf, Michael, and Muluneh, Benyam
- Subjects
- *
ACADEMIC medical centers , *PROFESSIONS , *SPECIALTY hospitals , *CONFIDENCE , *MIDDLE-income countries , *ATTITUDES of medical personnel , *CANCER chemotherapy , *RESEARCH methodology , *STAKEHOLDER analysis , *ACQUISITION of property , *INTERVIEWING , *PUBLIC administration , *CANCER treatment , *DRUGS , *INTERPROFESSIONAL relations , *DESCRIPTIVE statistics , *LOW-income countries , *PATIENT care , *THEMATIC analysis , *DRUG storage , *MEDICAL coding - Abstract
Background: The impact and downstream effects of the chemotherapy supply chain in Ethiopia are not well understood. The purpose of this study was to identify perceived gaps in supply chain and characterize their impact on patient care. Methods: A concurrent mixed-method study was conducted at a large academic cancer center in Ethiopia. In-depth interviews (IDIs) and surveys were completed in collaboration with external stakeholders with knowledge about chemotherapy supply chain in Ethiopia. Thematic coding was used for qualitative analysis of IDI and descriptive statistics were used to summarize quantitative survey data. Results: Six stakeholders participated in the IDIs and seven completed surveys. IDIs revealed that most chemotherapeutic agents are purchased by the Ethiopian Pharmaceutical Supply Agency (EPSA) and are distributed to cancer treatment centers. A free-market purchasing option also exists, but for chemotherapy obtained outside of government-subsidized channels, the potential for substandard or falsified chemotherapy was a concern. Participants expressed confidence that the correct treatment was administered to patients, but viewpoints on reliability and consistency of medication supply were variable. Quantitative data from the survey showed that participants were not confident that medications are prepared safely and correctly. Improper storage and manipulation of high-risk medications remain a significant risk to staff. Conclusions: This study provides insight from a healthcare staff perspective on how gaps in the chemotherapy supply chain process impact patient care in a low-income country. Inventory management, disruptions in supply chain, and product integrity were perceived as the largest gaps in the current chemotherapy supply chain structure. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF